Vincent Algalarrondo
Vincent Algalarrondo
Service de Cardiologie, Hôpital Bichat Claude Bernard, Université Paris Diderot, INSERM U-1180
Verified email at
Cited by
Cited by
Targeted therapies in pulmonary arterial hypertension
D Montani, MC Chaumais, C Guignabert, S Günther, B Girerd, X Jaïs, ...
Pharmacology & therapeutics 141 (2), 172-191, 2014
The value of basic research insights into atrial fibrillation mechanisms as a guide to therapeutic innovation: a critical analysis
J Heijman, V Algalarrondo, N Voigt, J Melka, XHT Wehrens, D Dobrev, ...
Cardiovascular research 109 (4), 467-479, 2016
Genotype–phenotype correlation and course of transthyretin familial amyloid polyneuropathies in France
LL Mariani, P Lozeron, M Théaudin, Z Mincheva, A Signate, B Ducot, ...
Annals of neurology 78 (6), 901-916, 2015
Extracorporeal cardiopulmonary resuscitation in out-of-hospital cardiac arrest: a registry study
W Bougouin, F Dumas, L Lamhaut, E Marijon, P Carli, A Combes, ...
European heart journal 41 (21), 1961-1971, 2020
Causes-of-death analysis of patients with cardiac resynchronization therapy: an analysis of the CeRtiTuDe cohort study
E Marijon, C Leclercq, K Narayanan, S Boveda, D Klug, ...
European heart journal 36 (41), 2767-2776, 2015
FAP neuropathy and emerging treatments
D Adams, M Théaudin, C Cauquil, V Algalarrondo, M Slama
Current Neurology and Neuroscience Reports 14 (3), 1-12, 2014
Extreme bradycardia after first doses of sofosbuvir and daclatasvir in patients receiving amiodarone: 2 cases including a rechallenge
S Renet, MC Chaumais, T Antonini, A Zhao, L Thomas, A Savoure, ...
Gastroenterology 149 (6), 1378-1380. e1, 2015
Prophylactic pacemaker implantation in familial amyloid polyneuropathy
V Algalarrondo, S Dinanian, C Juin, D Chemla, SL Bennani, C Sebag, ...
Heart Rhythm 9 (7), 1069-1075, 2012
Characteristics and clinical assessment of unexplained sudden cardiac arrest in the real-world setting: focus on idiopathic ventricular fibrillation
V Waldmann, W Bougouin, N Karam, F Dumas, A Sharifzadehgan, ...
European heart journal 39 (21), 1981-1987, 2018
Outcome and incidence of appropriate implantable cardioverter-defibrillator therapy in patients with cardiac amyloidosis
D Hamon, V Algalarrondo, E Gandjbakhch, F Extramiana, E Marijon, ...
International journal of cardiology 222, 562-568, 2016
TTR kinetic stabilizers and TTR gene silencing: a new era in therapy for familial amyloidotic polyneuropathies
D Adams, C Cauquil, C Labeyrie, G Beaudonnet, V Algalarrondo, ...
Expert Opinion on Pharmacotherapy 17 (6), 791-802, 2016
Primary prevention implantable cardioverter defibrillator (ICD) therapy in women—data from a multicenter French registry
R Providência, E Marijon, PD Lambiase, A Bouzeman, P Defaye, D Klug, ...
Journal of the American Heart Association 5 (2), e002756, 2016
Brugada syndrome and abnormal splicing of SCN5A in myotonic dystrophy type 1
K Wahbi, V Algalarrondo, HM Bécane, V Fressart, C Beldjord, K Azibi, ...
Archives of cardiovascular diseases 106 (12), 635-643, 2013
Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry
G Boriani, M Proietti, C Laroche, L Fauchier, F Marin, M Nabauer, ...
EP Europace 21 (7), 1013-1022, 2019
Should we perform an immediate coronary angiogram in all patients after cardiac arrest? Insights from a large French Registry
W Bougouin, F Dumas, N Karam, C Maupain, E Marijon, L Lamhaut, ...
JACC: Cardiovascular Interventions 11 (3), 249-256, 2018
Right atrial mechanisms of atrial fibrillation in a rat model of right heart disease
R Hiram, P Naud, F Xiong, D Al-u’datt, V Algalarrondo, MG Sirois, ...
Journal of the American College of Cardiology 74 (10), 1332-1347, 2019
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study
D Adams, M Polydefkis, A González-Duarte, J Wixner, AV Kristen, ...
The Lancet Neurology 20 (1), 49-59, 2021
Dual-vs. single-chamber defibrillators for primary prevention of sudden cardiac death: long-term follow-up of the Défibrillateur Automatique Implantable—Prévention Primaire …
P Defaye, S Boveda, D Klug, F Beganton, O Piot, K Narayanan, MC Périer, ...
EP Europace 19 (9), 1478-1484, 2017
Association between mutation size and cardiac involvement in myotonic dystrophy type 1: an analysis of the DM1-Heart Registry
C Chong-Nguyen, K Wahbi, V Algalarrondo, HM Bécane, ...
Circulation: Cardiovascular Genetics 10 (3), e001526, 2017
Interventricular Differences in β‐Adrenergic Responses in the Canine Heart: Role of Phosphodiesterases
CE Molina, DM Johnson, H Mehel, RL Spätjens, D Mika, V Algalarrondo, ...
Journal of the American Heart Association 3 (3), e000858, 2014
The system can't perform the operation now. Try again later.
Articles 1–20